tricalcium phosphate has been researched along with transforming growth factor beta in 208 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (7.69) | 18.2507 |
| 2000's | 105 (50.48) | 29.6817 |
| 2010's | 75 (36.06) | 24.3611 |
| 2020's | 12 (5.77) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, K; Irie, K; Kabasawa, Y; Nakajima, Y; Okuda, K; Ozawa, H; Sugimoto, M; Yoshie, H | 1 |
| Galante, JO; Gombotz, WR; Purchio, AF; Sumner, DR; Turner, TM; Urban, RM | 1 |
| Bünger, C; Lind, M; Nguyen, T; Ongpipattanakul, B; Overgaard, S; Søballe, K | 2 |
| Caplan, AI; Cassiede, P; Dennis, JE; Ma, F | 1 |
| Higuchi, T; Ishikawa, I; Kinoshita, A; Oda, S; Shizuya, T | 2 |
| Hang, YS; Lin, FH; Liu, HC; Sun, JS; Tsuang, YH; Yao, CH | 1 |
| Beck, LS; DeGuzman, L; Lee, WP; Nguyen, T; Ongpipattanakul, B; Osaka, G; Wong, R; Zioncheck, TF | 1 |
| Caplan, AI; Dennis, JE; Hanada, K | 1 |
| Hang, YS; Liao, CJ; Lin, FH; Liu, HC; Sun, JS; Tsuang, YH | 1 |
| Genge, BR; Ishikawa, Y; Sampath, TK; Wu, LN; Wuthier, RE | 1 |
| Boden, SD; Martin, GJ; Morone, MA; Moskovitz, PA; Ugbo, JL | 1 |
| Hamanishi, C; Matsuda, N; Ohura, K; Tanaka, S | 1 |
| Amoureux, JP; Frayssinet, P; Hildebrand, HF; Laffargue, P; Marchandise, X; Rtaimate, M | 1 |
| Aiolova, M; Catalano, A; Chakravarthy, P; Knaack, D; Lee, DD; Majahad, A; Tofighi, A | 1 |
| Blom, EJ; Burger, EH; Klein, CP; Klein-Nulend, J; Kurashina, K; van Waas, MA | 1 |
| Lohse, CM; Meraw, SJ; Reeve, CM; Sioussat, TM | 1 |
| Bünger, C; Glerup, H; Lin, M; Overgaard, S; Søballe, K | 1 |
| Cordaro, NM; DeYoung, DW; Szivek, JA | 1 |
| Alam, MI; Asahina, I; Enomoto, S; Ohmamiuda, K; Takahashi, K; Yokota, S | 1 |
| Kagayama, M; Kamakura, S; Katou, F; Motegi, K; Nakajo, S; Sasano, Y; Shimizu, T; Suzuki, O | 1 |
| Jansen, JA; Kuboki, Y; Mahmood, J; Spauwen, PH; Takita, H; van't Hof, MA; Vehof, JW | 1 |
| Arvinte, T; Schenk, RK; Steffen, T; Stoll, T | 1 |
| Blom, EJ; Burger, EH; Klein-Nulend, J; van Waas, MA; Yin, L | 1 |
| Blom, EJ; Burger, EH; Driessens, FC; Klein-Nulend, J; van Waas, MA; Wolke, JG | 1 |
| Blom, EJ; Burger, EH; Klein-Nulend, J; Kurashina, K; van Waas, MA; Wolke, JG | 1 |
| Boden, SD; Hutton, WC; Kim, HS; Louis-Ugbo, J; Mayr, M; Minamide, A; Murakami, H; Suh, DY | 1 |
| de Ruijter, AE; Haus, MT; Jansen, JA; Spauwen, PH; Vehof, JW | 1 |
| Hirata, G; Ikenoue, T; Iwamoto, Y; Jingushi, S; Okazaki, K; Sakai, A; Urabe, K | 1 |
| Blake, C; Boden, SD; D'Augusta, D; Jiao, A; Kim, HS; Li, RC; Louis-Ugbo, J; Mayr, MT; Peckham, S; Seeherman, H | 1 |
| Boden, SD; Heller, JG; Kang, J; Sandhu, H | 1 |
| Alves, ME; Blumenthal, NM; Koh-Kunst, G; Miranda, D; Sorensen, RG; Wikesjö, UM; Wozney, JM | 1 |
| Maus, U; Niedhart, C; Niethard, FU; Redmann, E; Schmidt-Rohlfing, B; Siebert, CH | 1 |
| Li, FB; Liao, WM; Long, HQ; Wang, HX; Wang, YJ | 1 |
| Chueh, SC; Hsu, FY; Huang, YC; Lin, FH; Sun, JS; Wang, YJ | 1 |
| Choi, SM; Chung, CP; Han, SB; Kim, TI; Ku, Y; Lee, SJ; Lee, YM; Nam, SH; Rhyu, IC; Seol, YJ | 1 |
| Geng-ting, D; Kai, T; Shao-qing, G | 1 |
| Hedberg, EL; Jansen, JA; Mikos, AG; Padron, NT; Ruhe, PQ; Spauwen, PH | 1 |
| Chen, W; Ling, X; Liu, S; Wang, G | 1 |
| Blake, CA; Bouxsein, ML; D'Augusta, D; Kim, H; Li, RH; Li, XJ; Seeherman, HJ; Wozney, JM | 1 |
| Bragdon, CR; Doherty, AM; Harris, WH; Jasty, M; Li, XJ; Rubash, HE; Seeherman, H | 1 |
| Dai, K; Lou, J; Tang, T; Xu, X; Yu, C | 1 |
| Chen, X; Tian, W; Yang, L | 1 |
| Jansen, JA; Kroese-Deutman, HC; Ruhé, PQ; Spauwen, PH; Wolke, JG | 1 |
| DeYoung, DW; Hajdu, SD; Nelson, ER; Szivek, JA; Yablonski, K | 1 |
| Brooks, RA; Clarke, SA; Lee, PT; Rushton, N | 2 |
| Kim, HD; Li, RH; Wozney, JM | 1 |
| Hashizume, H; Kawakami, M; Minamide, A; Sakata, R; Tamaki, T; Yoshida, M | 1 |
| Trion, A; van der Laarse, A | 1 |
| Iwata, H; Kubo, Y; Ohyama, T; Taki, W | 1 |
| Bogdanske, JJ; Devitt, J; Edwards, RB; Markel, MD; Seeherman, HJ; Vanderby, R | 1 |
| Inoue, H; Matsushita, N; Miyamoto, S; Nozaki, K; Okada, T; Takaoka, K; Terai, H | 1 |
| Kinoshita, A; Sorensen, RG; Wikesjö, UM; Wozney, JM | 1 |
| Aiolova, M; Bouxsein, M; Kim, H; Li, R; Li, XJ; Seeherman, HJ; Wozney, JM | 1 |
| Fritz, DT; Jiang, S; Liu, D; Rogers, MB; Xu, J | 1 |
| Kamakura, S; Nakajo, S; Sasano, Y; Suzuki, O | 1 |
| Jansen, JA; Kroese-Deutman, HC; Ruhé, PQ; Spauwen, PH | 1 |
| El-Ghannam, A; Mehta, J; Ning, CQ | 1 |
| Bigi, A; Bracci, B; Fini, M; Giardino, R; Panzavolta, S; Sturba, L; Torricelli, P | 1 |
| Demiralp, B; Eratalay, K; Keçeli, HG; Muhtaroğullar, M; Serper, A | 1 |
| Huse, RO; Jansen, JA; Quinten Ruhe, P; Wolke, JG | 1 |
| Chung, CP; Kim, KH; Lee, JY; Lee, SJ; Lee, YM; Park, YJ; Rhyu, IC; Seol, YJ | 1 |
| Hurschler, C; Thorey, F; Windhagen, H; Wirth, CJ; Witte, F | 1 |
| Chai, JK; Cho, KS; Choi, SH; Kim, CK; Kim, CS; Kim, J; Kim, JI | 1 |
| Hedberg, EL; Jansen, JA; Kroeze-Deutman, H; Kuboki, Y; Mikos, AG; Ruhé, PQ; Takita, H; Vehof, JW | 1 |
| Cao, T; Ho, KH; Hutmacher, DW; Rai, B; Teoh, SH | 1 |
| DeYoung, DW; Garrison, BK; Margolis, DS; Nelson, E; Szivek, JA; Vaidyanathan, RK | 1 |
| Liang, G; Oh, S; Ong, JL; Ran, J; Yang, Y; Yin, G; Zheng, C; Zhou, D | 1 |
| de Groot, K; Hunziker, EB; Liu, YM | 1 |
| Tabata, Y; Takahashi, Y; Yamamoto, M | 1 |
| Imai, Y; Inoue, H; Miyamoto, S; Nozaki, K; Okada, T; Takaoka, K; Terai, H; Yoneda, M | 1 |
| Arosarena, OA; Collins, WL | 1 |
| De Ranieri, A; Hallab, NJ; Kuroda, S; Leven, RM; Shott, S; Sumner, DR; Virdi, AS | 1 |
| Barnes, B; Boden, SD; Louis-Ugbo, J; Minamide, A; Park, JS; Park, MS; Tomak, PR | 1 |
| Boerman, OC; Jansen, JA; Mikos, AG; Ruhé, PQ; Russel, FG; Spauwen, PH | 2 |
| Blumenthal, NM; Miranda, DA; Sorensen, RG; Wikesjö, UM; Wozney, JM | 1 |
| Ho, KH; Rai, B; Teoh, SH | 1 |
| Campbell, MJ; Carreon, LY; Dimar, JR; Glassman, SD; Johnson, JR; Puno, RM | 1 |
| Hoshino, M; Miyamoto, S; Nakamura, H; Namikawa, T; Ninomiya, T; Suzuki, E; Takahashi, N; Takaoka, K; Terai, H; Toyoda, H | 1 |
| Aiolova, M; Bouxsein, M; Kim, H; Li, R; Li, XJ; Seeherman, H; Smith-Adaline, EA; Wozney, JM | 1 |
| Cho, IH; Cho, KS; Choi, SH; Han, DK; Hong, SJ; Jung, UW; Kim, CK; Kim, CS | 1 |
| Wozney, JM | 1 |
| Namikawa, T; Takaoka, K; Terai, H | 1 |
| Anada, T; Honda, Y; Kamakura, S; Nakamura, M; Sugawara, S; Suzuki, O | 1 |
| Chen, WJ; Iwamoto, Y; Jingushi, K; Jingushi, S | 1 |
| Egi, T; Hoshino, M; Namikawa, T; Takaoka, K; Terai, H | 1 |
| Carstens, MH; Chao, M; Donovan, T; Sotelo, C | 1 |
| Azari, K; Bidic, S; Hollinger, JO; Li, XJ; Rogers, L; Seeherman, HJ; Wozney, JM | 1 |
| Dony, C; Hellerbrand, K; Pippig, SD; Poehling, S; Schütz, A; Siedler, M | 1 |
| Boerman, OC; Jansen, JA; Leewenburgh, SC; Siebers, MC; Walboomers, XF; Wolke, JC | 1 |
| Chu, TM; Stewart, RL; Turner, CH; Warden, SJ | 1 |
| Cao, X; Chen, J; Liu, C | 1 |
| Alam, S; Hase, T; Marukawa, K; Nakagawa, K; Ohara, T; Takazakura, D; Ueki, K | 1 |
| Buser, D; de Groot, K; Hunziker, EB; Huse, RO; Liu, Y | 1 |
| Deng, XH; Hays, P; Kawamura, S; Ma, CB; Rodeo, SA; Schneidkraut, J; Ying, L | 1 |
| Buser, D; Enggist, L; Hunziker, EB; Kuffer, AF; Liu, Y | 1 |
| Hoshino, M; Kato, M; Namikawa, T; Taguchi, S; Takaoka, K; Terai, H | 1 |
| Cunningham, L; El-Ghannam, A; Hart, A; Pienkowski, D | 1 |
| Bai, J; Fei, Z; Hu, Y; Lu, R; Song, H; Wu, D; Wu, H | 1 |
| Motta, T; Pluhar, GE; Santoni, BG; Wheeler, DL | 1 |
| Ewers, R; Goriwoda, W; Hoering, B; Lagogiannis, G; Moser, D; Redl, H; Schopper, C; Spassova, E | 1 |
| Cunningham, ME; Lane, JM; Tomin, EA; Vergun-Cuomo, A; Weiland, A | 1 |
| Jansen, JA; Link, DP; Mikos, AG; van den Beucken, JJ; van den Dolder, J; Wolke, JG | 1 |
| Cochran, DL; Ehrbar, M; Hämmerle, CH; Jung, RE; Thoma, DS; Weber, FE | 1 |
| Richter, PW; Ripamonti, U; Thomas, ME | 1 |
| Andereya, S; Gravius, S; Maus, U; Niedhart, C; Ohnsorge, JA; Siebert, CH | 1 |
| Bian, Z; Fan, M; Jansen, JA; van den Dolder, J; Walboomers, XF; Yang, F; Yang, X | 1 |
| Cui, F; Feng, Q; Li, X; van Blitterswijk, CA; Watari, F | 1 |
| Abarrategi, A; Aranaz, I; López-Lacomba, JL; Moreno-Vicente, C; Ramos, V; Sanz Casado, JV | 1 |
| Agata, H; Asahina, I; Kagami, H; Sagara, H; Shinohara, Y; Uchida, M | 1 |
| Chang, T; Li, Q; Mu, X; Xiong, Z; Yu, D | 1 |
| Fan, HS; Li, DX; Luxbacher, T; Xiao, YM; Zhang, HJ; Zhang, XD; Zhu, XD | 1 |
| Kobayashi, H; Lu, Y; Markel, M; Nemke, B; Perrier, M; Peterson, A | 1 |
| Clyde, V; Cole, G; Hartup, BK; Paul-Murphy, J; Sample, S; Schaefer, S; Seeherman, HJ | 1 |
| Bai, B; Chen, D; Chen, Y; Lew, M; Wu, J; Xu, Q; Ye, J; Yin, Z; Zeng, Y | 1 |
| Blake, F; Gerressen, M; Hanisch, O; Hölzle, F; Kolk, A; Maciejewski, O; Riediger, D; Smeets, R; Spiekermann, H; Stein, J | 1 |
| Allori, AC; Lin, CD; Nguyen, PD; Ricci, JL; Saadeh, PB; Schachar, JS; Warren, SM | 1 |
| Han, I; Kim, MR; Kim, SJ; Oh, JS; Shin, SW | 1 |
| Baker, KC; Herkowitz, HN; Majid, K; Reyes-Trocchia, A; Tseng, MD | 1 |
| Bi, L; Cheng, W; Fan, H; Pei, G | 1 |
| E, LL; Liu, HC; Lv, Y; Wang, DS; Wang, JZ; Wu, X; Xu, LL | 1 |
| Duan, B; Wang, M | 1 |
| Ferreira, FM; Larson, R; Shibli, JA; Zétola, A | 1 |
| Detamore, MS; Tang, M; Weir, MD; Xu, HH; Zhao, L | 1 |
| Lai, RF; Liu, XN; Shen, S; Zhao, QT | 1 |
| Abdullah, KG; Benzel, EC; Mroz, TE; Steinmetz, MP | 1 |
| Ergun, C; Lutz, R; Nkenke, E; Ramazanoglu, M; Schlegel, KA; von Wilmowsky, C | 1 |
| Li, Z; Liu, J; Wang, H; Zhang, W | 1 |
| Jiang, X; Liu, C; Wei, J; Xia, L; Xu, Y; Ye, D; Zeng, D; Zhang, Z | 1 |
| Fujita, N; Ishida, K; Kubo, S; Kuroda, R; Kurosaka, M; Matsumoto, T; Matsushita, T; Sasaki, K; Tabata, Y | 1 |
| Ferretti, C; Klar, RM; Ripamonti, U; Roden, LC | 1 |
| Bae, JH; Choi, KH; Kim, HJ; Kim, SE; Kim, SJ; Song, HR; Yang, JH; Yun, YP | 1 |
| Li, L; Lin, HT; Wang, J; Zheng, YX | 1 |
| Busso, N; Ea, HK | 1 |
| Alkhraisat, MH; Berenguer, B; González-Meli, B; López, Y; López-Cabarcos, E; Maldonado, E; Martínez, ML; Martínez-Álvarez, C; Martínez-Sanz, E; Paradas, I | 1 |
| Chang, J; Fei, L; Lin, K; Sun, J; Wang, C; Xue, Y | 1 |
| Chen, SH; Leng, Y; Qin, L; Wang, DP; Wang, XL; Xie, XH; Yao, D; Zhang, G; Zheng, LZ | 1 |
| Chesnoiu-Matei, I; Clark, E; Cretiu Vasiliu, CE; Nguyen, PD; Ricci, JL; Smay, JE; Szpalski, C; Warren, SM | 1 |
| Baek, HS; Chung, IK; Hwang, DS; Jeong, JS; Kim, BJ; Kim, CH; Kwon, TK; Shin, SH | 1 |
| Cho, KS; Choi, SH; Jeong, IH; Jung, IH; Jung, UW; Kim, CS; Kim, JW; Lee, KI; Yun, JH | 1 |
| Gong, C; Huang, HC; Li, LY; Liu, CR; Miao, J; Xia, Q; Yang, Q | 1 |
| Liu, B; Lun, DX | 1 |
| Li, R; Li, XJ; Parkington, J; Seeherman, HJ; Smith, E; Wozney, JM | 1 |
| Jokinen, J; Lappalainen, OP; Mannerström, B; Miettinen, S; Nieminen, E; Patrikoski, M; Sándor, GK; Seppänen, R; Tuovinen, VJ; Wolff, J | 1 |
| Desai, SC; Nussenbaum, B; Sclaroff, A | 1 |
| Amaral, R; Coutinho, E; Marchi, L; Oliveira, L; Pimenta, L | 1 |
| Fang, H; Wu, L; Yang, X | 1 |
| Cunningham, L; El-Ghannam, A; Hart, A; White, D | 1 |
| Baek, HR; Lee, HK; Lee, JH; Lee, KM; Ryu, HS; Ryu, MY; Seo, JH | 1 |
| Anchieta, RB; Coelho, PG; Guastaldi, FP; Janal, MN; Jimbo, R; Machado, LS; Marin, C; Montclare, J; Tovar, N; Yoo, D | 1 |
| Liu, C; Yang, K; Yuan, Y; Zhang, J; Zhou, H | 1 |
| Brocher, J; Janicki, P; Mueller-Ladner, U; Neumann, E; Richter, W; Seebach, E; Voltz, P | 1 |
| Fineberg, SJ; Marquez-Lara, A; Nandyala, SV; Pelton, M; Singh, K | 1 |
| Adam, CJ; Askin, GN; Hutmacher, DW; Labrom, RD; Saifzadeh, S; Woodruff, M; Yong, MR | 1 |
| Bhandari, M; Christensen, J; Huard, F; Koval, KJ; Lyon, T; Sanchez, EG; Scheele, W; Valentin, A | 1 |
| Collinge, C | 1 |
| Abarrategi, A; del Monte, F; Ferrer, ML; Gutiérrez, MC; Guzmán, R; López-Lacomba, JL; Nardecchia, S; Ramos, V | 1 |
| Huang, L; Wang, Y; Xu, Z; Zhang, L | 1 |
| Chen, L; Feng, Y; Gu, Y; Liu, HL; Niu, HY; Wang, CZ; Yang, HL; Zhang, C; Zhu, XS | 1 |
| Dard, M; Gruber, RM; Krohn, S; Lange, K; Mauth, C; Molenberg, A; Perske, C; Schliephake, H | 1 |
| Breitbart, EA; Doyle, E; Lin, S; Liporace, FA; Paglia, DN; Yoon, RS | 1 |
| Brown Baer, PR; Dadsetan, M; Guda, T; LeGeros, JP; LeGeros, RZ; Lu, L; Mijares, D; Runge, MB; Silliman, DT; Wenke, JC; Yaszemski, MJ | 1 |
| Akiyama, K; Hara, ES; Kuboki, T; Nakajima, R; Oida, Y; Ono, M; Pham, HT; Shinkawa, S; Sonoyama, W; Yamamoto, K | 1 |
| Browne, C; Jiang, T; Kang, Y; Yang, J; Yang, Y | 1 |
| Choi, SH; Hong, JY; Jung, UW; Lee, EU; Lee, JS; Lim, HC | 1 |
| Gerich, T; Hildebrandt, K; Krettek, C; Müller, CW; Rosado Balmayor, E; van Griensven, M | 1 |
| Darr, A; Donovan, A; Hollinger, JO; Kim, J; Magno, MH; McBride, S | 1 |
| Jang, KY; Kim, DY; Kim, JR; Lee, KB | 1 |
| Chen, D; Chen, M; He, L; Ling, J; Mao, JJ; Wang, C; Xiang, L; Yang, G; Zhou, C | 1 |
| Berkland, CJ; Detamore, MS; Easley, JT; Galbraith, RA; Gupta, V; Key, VH; Mellott, AJ; Mohan, N; Palmer, RH; Sridharan, BP | 1 |
| Alt, V; Van Lieshout, EM | 1 |
| Deng, L; Kang, P; Li, D; Tan, Z; Xie, X; Yang, Z | 1 |
| Ding, S; Huang, B; Liu, C; Tian, Y; Yuan, Y; Zhang, J | 1 |
| Bernstein, A; Kissling, S; Mayr, HO; Pilz, IH; Seidenstuecker, M; Suedkamp, NP | 1 |
| Chang, D; Fu, C; Fu, Y; Liu, S; Liu, Y; Sun, Y; Tay, FR; Wang, G; Zhou, Y | 1 |
| Ichikawa, K; Imai, Y; Mamoto, K; Minoda, Y; Mizokawa, S; Nakamura, H; Ohta, Y; Takaoka, K | 1 |
| Malham, GM; Parker, RM | 1 |
| Deng, Y; Jiang, C; Li, C; Li, N; Li, T; Peng, M; Wang, J | 1 |
| Lu, WW; Wang, C; Wang, M | 2 |
| Gu, F; Huang, Y; Luo, G | 1 |
| Wang, C; Wang, M; Zhao, Q | 1 |
| Bahrami, N; Bayat, M; Mohamadnia, A; Shojaei, P; Shojaei, S | 1 |
| Hing, KA; Mafina, MK; Sullivan, AC | 1 |
| Huang, B; Liu, C; Ma, Y; Tian, Y; Yuan, Y; Zhang, W | 1 |
| Hirakawa, Y; Ichikawa, K; Ito, Y; Manaka, T; Nakamura, H; Orita, K | 1 |
| Auslander, A; Hammoudeh, J; Jedrzejewski, B; Leland, H; Liang, F; Magee, W; Maniskas, S; Swanson, J; Urata, M | 1 |
| Budde, S; Floerkemeier, T; Hurschler, C; Thorey, F; Wellmann, M; Windhagen, H | 1 |
| Gan, D; Liu, M; Lu, X; Tan, H; Wang, K; Xu, T | 1 |
| Aubert, L; Audonnet, S; Bercu, NB; Boulmedais, F; Bour, C; Dubus, M; Entz, L; Gangloff, SC; Kerdjoudj, H; Mauprivez, C; Rammal, H | 1 |
| Edranov, SS; Kalinichenko, SG; Kostiv, RY; Matveeva, NY | 1 |
| Liu, C; Ma, C; Ma, Z; Wang, J; Yang, F | 1 |
| Han, SH; Jung, SH; Lee, JH | 1 |
| Ho, ML; Tai, IC; Teng, FY; Tseng, CC; Wang, JW; Wang, MW; Wang, YJ; Weng, LW | 1 |
| Akiyama, S; Chazono, M; Inagaki, N; Kakuta, A; Kitasato, S; Komaki, H; Marumo, K; Tanaka, T | 1 |
| Choi, D; Lee, S; Nam, W; Shim, JH | 1 |
| Barba, A; Franch, J; Ginebra, MP; Maazouz, Y; Rappe, K | 1 |
| Jo, DW; Kim, KS; Kim, SY; Lee, HJ; Park, SA; Park, SY | 1 |
| Bay-Jensen, AC; Bondesen, S; Davies, MJ; Hawkins, CL; Juhl, P; Karsdal, MA; Siebuhr, AS | 1 |
| Chang, HH; Chao, YL; Lin, LD; Wang, TM | 1 |
| Byun, SH; Choi, HG; Hong, SJ; Lim, HK; On, SW; Ryu, JI; Yang, BE; Yi, SM | 1 |
| Aung, KT; Dang, AT; Hara, ES; Ishibashi, K; Kuboki, T; Mikai, A; Nawachi, K; Ono, M; Ono-Kimura, A; Oohashi, T; Tanaka, Y; Tosa, I | 1 |
| Bal, Z; Hirai, H; Kaito, T; Kodama, J; Kushioka, J; Makino, T; Nakagawa, S; Okada, R; Okada, S; Takenaka, S; Tateiwa, D; Tsukazaki, H; Ukon, Y | 1 |
| Ha, Y; Hwang, GY; Kang, JI; Kim, KN; Lee, HL; Lee, HY | 1 |
| Caron, MMJ; Cremers, A; Housmans, BAC; Peffers, MJ; Smagul, A; Stassen, RHMJ; Surtel, DAM; van den Akker, GGH; van Rhijn, LW; Welting, TJM | 1 |
7 review(s) available for tricalcium phosphate and transforming growth factor beta
| Article | Year |
|---|---|
Vascular smooth muscle cells and calcification in atherosclerosis.
Topics: Apoptosis; Arteriosclerosis; Bone Development; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcinosis; Calcium Phosphates; Cell Differentiation; Cytoplasmic Vesicles; Lipid Metabolism; Macrophages; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteopontin; Sialoglycoproteins; Transforming Growth Factor beta | 2004 |
[Experimental spinal fusion in a rabbit model with new drug delivery system for BMP].
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Drug Delivery Systems; Models, Animal; Polyesters; Polymers; Rabbits; Spinal Fusion; Transforming Growth Factor beta | 2006 |
The state of lumbar fusion extenders.
Topics: Bone Morphogenetic Protein 2; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Humans; Intervertebral Disc Degeneration; Lumbar Vertebrae; Recombinant Proteins; Spinal Fusion; Spondylosis; Transforming Growth Factor beta | 2011 |
Biomimetic matrices self-initiating the induction of bone formation.
Topics: Animals; Biomimetic Materials; Bone Morphogenetic Proteins; Calcium Phosphates; Cell Differentiation; Durapatite; Humans; Osteogenesis; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2011 |
The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis).
Topics: Apoptosis; Arthritis, Gouty; Biomarkers; Calcium Phosphates; Carrier Proteins; Chondrocalcinosis; Endothelial Cells; Gout; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein; Proteolysis; Transforming Growth Factor beta; Uric Acid | 2012 |
Current application of β-tricalcium phosphate composites in orthopaedics.
Topics: Biocompatible Materials; Bone Marrow; Bone Morphogenetic Protein 2; Calcium Phosphates; Durapatite; Factor XIIIa; Humans; Ions; Metals; Orthopedic Procedures; Orthopedics; Platelet-Rich Plasma; Polyesters; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2012 |
Alternatives to Autologous Bone Graft in Alveolar Cleft Reconstruction: The State of Alveolar Tissue Engineering.
Topics: Alveolar Process; Autografts; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 7; Bone Regeneration; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Cleft Palate; Durapatite; Humans; Maxilla; Plastic Surgery Procedures; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta; Transplantation, Autologous | 2018 |
5 trial(s) available for tricalcium phosphate and transforming growth factor beta
| Article | Year |
|---|---|
Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
Topics: Awards and Prizes; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Drug Implants; Female; Follow-Up Studies; Humans; Ilium; Internal Fixators; Intervertebral Disc Displacement; Low Back Pain; Lumbosacral Region; Male; Middle Aged; Pilot Projects; Prospective Studies; Recombinant Proteins; Reoperation; Spinal Fusion; Transforming Growth Factor beta; Treatment Outcome | 2002 |
Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
Topics: Adult; Aged; Aged, 80 and over; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Transplantation; Calcium Phosphates; Collagen; Drug Carriers; Durapatite; Female; Follow-Up Studies; Humans; Lumbar Vertebrae; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Smoking; Spinal Diseases; Spinal Fusion; Statistics, Nonparametric; Transforming Growth Factor beta | 2005 |
A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
Topics: Adult; Aged; Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Phosphates; Disability Evaluation; Female; Humans; Intervertebral Disc Degeneration; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Prospective Studies; Recombinant Proteins; Silicates; Spinal Fusion; Spine; Tomography, X-Ray Computed; Transforming Growth Factor beta; Treatment Outcome | 2013 |
Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
Topics: Adult; Aged; Aged, 80 and over; Bone Morphogenetic Protein 2; Calcium Compounds; Calcium Phosphates; Cohort Studies; Female; Follow-Up Studies; Humans; Lumbar Vertebrae; Male; Middle Aged; Minimally Invasive Surgical Procedures; Postoperative Complications; Prospective Studies; Radiography; Recombinant Proteins; Silicates; Spinal Fusion; Transforming Growth Factor beta | 2014 |
Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial.
Topics: Adult; Bone Morphogenetic Protein 2; Bone Nails; Calcium Phosphates; Diaphyses; Dose-Response Relationship, Drug; Double-Blind Method; Feasibility Studies; Female; Fracture Fixation, Intramedullary; Fracture Healing; Fractures, Closed; Humans; Injections, Intralesional; Male; Postoperative Complications; Recombinant Proteins; Tibial Fractures; Time Factors; Transforming Growth Factor beta | 2013 |
196 other study(ies) available for tricalcium phosphate and transforming growth factor beta
| Article | Year |
|---|---|
Transforming growth factor-beta 1 coated beta-tricalcium phosphate pellets stimulate healing of experimental bone defects of rat calvariae.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Drug Combinations; Drug Implants; Humans; Image Processing, Computer-Assisted; Isoenzymes; Male; Microscopy, Confocal; Osteoblasts; Osteoclasts; Rats; Rats, Wistar; Recombinant Proteins; Skull; Tartrate-Resistant Acid Phosphatase; Transforming Growth Factor beta; Wound Healing | 1995 |
Enhancement of bone ingrowth by transforming growth factor-beta.
Topics: Animals; Bone Nails; Calcium Phosphates; Dogs; Durapatite; Humerus; Male; Microscopy, Electron, Scanning; Osseointegration; Recombinant Proteins; Time Factors; Titanium; Transforming Growth Factor beta | 1995 |
Transforming growth factor-beta 1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants: an experimental study in dogs.
Topics: Adsorption; Animals; Bone Cements; Bone Screws; Calcium Phosphates; Disease Models, Animal; Dogs; Fracture Healing; Gait; Materials Testing; Osseointegration; Recombinant Proteins; Transforming Growth Factor beta; Weight-Bearing | 1996 |
Transforming growth factor-beta 1 enhances bone healing to unloaded tricalcium phosphate coated implants: an experimental study in dogs.
Topics: Animals; Bone and Bones; Calcium Phosphates; Ceramics; Dogs; Evaluation Studies as Topic; Humans; Joint Prosthesis; Osseointegration; Recombinant Proteins; Transforming Growth Factor beta; Wound Healing | 1996 |
Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro.
Topics: Alkaline Phosphatase; Animals; Becaplermin; Bone Development; Bone Marrow; Bone Marrow Cells; Calcium Phosphates; Cartilage; Cell Count; Cell Differentiation; Cell Division; Cell Separation; Cell Transplantation; Ceramics; Humans; Male; Platelet-Derived Growth Factor; Porosity; Proto-Oncogene Proteins c-sis; Rats; Rats, Inbred F344; Recombinant Proteins; Stem Cells; Transforming Growth Factor beta; Trypsin | 1996 |
[Ectopic bone induction in recombinant human bone morphogenetic protein-2 (rhBMP-2) combined with biphasic calcium phosphate (BCP)].
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Humans; Male; Ossification, Heterotopic; Osteogenesis; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 1996 |
Effects of calcium phosphate bioceramics on skeletal muscle cells.
Topics: Animals; Calcium Phosphates; Cell Division; Cells, Cultured; Female; Male; Materials Testing; Metal Ceramic Alloys; Muscle, Skeletal; Rats; Rats, Wistar; Transforming Growth Factor beta | 1997 |
Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler.
Topics: Amylopectin; Animals; Biocompatible Materials; Bone and Bones; Bone Cements; Calcium Phosphates; Fractures, Bone; Humans; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 1997 |
Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium; Calcium Phosphates; Cell Differentiation; Cell Division; Cells, Cultured; Ceramics; Drug Synergism; Fibroblast Growth Factor 2; Hematopoietic Stem Cells; Male; Mesoderm; Mitogens; Osteogenesis; Rats; Rats, Inbred F344; Transforming Growth Factor beta | 1997 |
The effects of calcium phosphate particles on the growth of osteoblasts.
Topics: Alkaline Phosphatase; Animals; Animals, Newborn; Calcium Phosphates; Calcium Pyrophosphate; Cell Count; Cell Division; Cells, Cultured; Ceramics; Culture Media; Dinoprostone; Durapatite; Osteoblasts; Powders; Rats; Rats, Wistar; Transforming Growth Factor beta | 1997 |
Effect of osteogenic protein-1 on the development and mineralization of primary cultures of avian growth plate chondrocytes: modulation by retinoic acid.
Topics: Alkaline Phosphatase; Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcification, Physiologic; Calcium Phosphates; Cartilage, Articular; Cell Differentiation; Cell Division; Cells, Cultured; Chickens; Growth Plate; Kinetics; L-Lactate Dehydrogenase; Proteoglycans; Time Factors; Transforming Growth Factor beta; Tretinoin | 1997 |
Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2).
Topics: Adsorption; Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Dermatologic Surgical Procedures; Drug Carriers; Drug Combinations; Giant Cells; Humans; Hydroxyapatites; Male; Ossification, Heterotopic; Osteoblasts; Osteogenesis; Particle Size; Pressure; Prostheses and Implants; Rats; Rats, Wistar; Recombinant Proteins; Surface Properties; Transforming Growth Factor beta | 1997 |
Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Dose-Response Relationship, Drug; Drug Carriers; Hydroxyapatites; Ilium; Laminectomy; Lumbar Vertebrae; Macaca mulatta; Osseointegration; Recombinant Proteins; Spinal Fusion; Tomography, X-Ray Computed; Transforming Growth Factor beta | 1999 |
Healing of segmental bone defects in rats induced by a beta-TCP-MCPM cement combined with rhBMP-2.
Topics: Animals; Biomechanical Phenomena; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Nails; Bone Plates; Calcium Phosphates; Drug Carriers; Femoral Fractures; Fracture Healing; Humans; Male; Materials Testing; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta | 1999 |
Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects.
Topics: Absorptiometry, Photon; Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Femur; Humans; Implants, Experimental; Magnetic Resonance Spectroscopy; Male; Materials Testing; Osseointegration; Osteogenesis; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 1999 |
alpha-BSM: a biomimetic bone substitute and drug delivery vehicle.
Topics: Animals; Anti-Bacterial Agents; Biomechanical Phenomena; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Dogs; Drug Carriers; Female; Femur; Gentamicins; In Vitro Techniques; Male; Prostheses and Implants; Rabbits; Radius; Recombinant Proteins; Transforming Growth Factor beta; Wound Healing | 1999 |
Transforming growth factor-beta1 incorporated during setting in calcium phosphate cement stimulates bone cell differentiation in vitro.
Topics: 1-Methyl-3-isobutylxanthine; Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Bone Cements; Bone Regeneration; Calcitriol; Calcium Phosphates; Cell Differentiation; Cells, Cultured; Humans; Osteoblasts; Parathyroid Hormone; Rats; Recombinant Proteins; Transforming Growth Factor beta | 2000 |
Treatment of peri-implant defects with combination growth factor cement.
Topics: Absorbable Implants; Alveolar Bone Loss; Animals; Bicuspid; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Collagen; Coloring Agents; Dental Implantation, Endosseous; Dental Implants; Dogs; Feasibility Studies; Fibroblast Growth Factor 2; Follow-Up Studies; Growth Substances; Guided Tissue Regeneration, Periodontal; Image Processing, Computer-Assisted; Male; Membranes, Artificial; Osseointegration; Platelet-Derived Growth Factor; Random Allocation; Titanium; Transforming Growth Factor beta | 2000 |
Transforming growth factor-beta1 adsorbed to tricalciumphosphate coated implants increases peri-implant bone remodeling.
Topics: Adsorption; Animals; Bone Remodeling; Calcium Phosphates; Dogs; Fracture Healing; Prostheses and Implants; Recombinant Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Surface enhancements accelerate bone bonding to CPC-coated strain gauges.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcium Phosphates; Calcium Sulfate; Ceramics; Coated Materials, Biocompatible; Endothelium; Femur; Follow-Up Studies; Kinetics; Ligands; Male; Materials Testing; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Surface Properties; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2.
Topics: Alkaline Phosphatase; Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Ceramics; Connective Tissue; Connective Tissue Cells; Delayed-Action Preparations; Drug Carriers; Drug Implants; Durapatite; Humans; Male; Materials Testing; Microscopy, Electron, Scanning; Osteoblasts; Osteocytes; Osteogenesis; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 2001 |
Implantation of octacalcium phosphate combined with transforming growth factor-beta1 enhances bone repair as well as resorption of the implant in rat skull defects.
Topics: Animals; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Drug Carriers; Drug Implants; Histocytochemistry; Humans; Male; Rats; Rats, Wistar; Recombinant Proteins; Skull; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium; Calcium Phosphates; Cattle; Coated Materials, Biocompatible; Implants, Experimental; Osteocalcin; Osteogenesis; Porosity; Rats; Rats, Wistar; Recombinant Proteins; Titanium; Transforming Growth Factor beta | 2001 |
Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery.
Topics: Animals; Biocompatible Materials; Biomechanical Phenomena; Calcium Phosphates; Ceramics; Equipment Design; Female; Internal Fixators; Male; Orthopedic Fixation Devices; Osseointegration; Papio; Prostheses and Implants; Range of Motion, Articular; Sheep; Spinal Fusion; Spine; Tomography, X-Ray Computed; Transforming Growth Factor beta; Transforming Growth Factor beta3 | 2001 |
Transforming growth factor-beta1 incorporated in calcium phosphate cement stimulates osteotransductivity in rat calvarial bone defects.
Topics: Animals; Bone Cements; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Humans; Male; Rats; Rats, Wistar; Recombinant Proteins; Skull; Transforming Growth Factor beta | 2001 |
Transforming growth factor-beta1 incorporation in a calcium phosphate bone cement: material properties and release characteristics.
Topics: Bone Cements; Bone Substitutes; Calcium Phosphates; Compressive Strength; Delayed-Action Preparations; Humans; In Vitro Techniques; Materials Testing; Microscopy, Electron, Scanning; Recombinant Proteins; Transforming Growth Factor beta; X-Ray Diffraction | 2002 |
Transforming growth factor-beta1 incorporation in an alpha-tricalcium phosphate/dicalcium phosphate dihydrate/tetracalcium phosphate monoxide cement: release characteristics and physicochemical properties.
Topics: Animals; Bone Cements; Calcium Phosphates; Chemical Phenomena; Chemistry, Physical; Compressive Strength; Delayed-Action Preparations; Humans; In Vitro Techniques; Materials Testing; Microscopy, Electron; Microscopy, Electron, Scanning; Rats; Recombinant Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1; X-Ray Diffraction | 2002 |
Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Topics: Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Ceramics; Collagen Type I; Compressive Strength; Drug Administration Routes; Drug Carriers; Drug Evaluation, Preclinical; Durapatite; Humans; Implants, Experimental; Lumbar Vertebrae; Lumbosacral Region; Macaca mulatta; Models, Animal; Osteogenesis; Rabbits; Recombinant Proteins; Spinal Fusion; Surgical Sponges; Tomography, X-Ray Computed; Transforming Growth Factor beta; Treatment Outcome | 2002 |
Bone formation in transforming growth factor beta-I-loaded titanium fiber mesh implants.
Topics: Animals; Calcium Phosphates; Coated Materials, Biocompatible; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Male; Matched-Pair Analysis; Microscopy, Fluorescence; Osteogenesis; Porosity; Prostheses and Implants; Rabbits; Recombinant Proteins; Skull; Statistics as Topic; Surgical Mesh; Titanium; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2002 |
Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograft.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Transplantation; Calcium Phosphates; Female; Immunohistochemistry; Male; Models, Animal; Muscle, Skeletal; Osteogenesis; Rabbits; Sensitivity and Specificity; Tissue Engineering; Transforming Growth Factor beta; Transplantation, Autologous | 2002 |
Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model.
Topics: Animals; Area Under Curve; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Collagen; Drug Carriers; Female; Half-Life; Humans; Iodine Radioisotopes; Lumbar Vertebrae; Models, Animal; Rabbits; Radiography; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta | 2002 |
Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Cementogenesis; Collagen; Drug Carriers; Drug Implants; Humans; Oral Surgical Procedures; Papio; Periodontal Ligament; Postoperative Care; Recombinant Proteins; Regeneration; Root Resorption; Tooth Ankylosis; Transforming Growth Factor beta | 2002 |
Stimulation of bone formation with an in situ setting tricalcium phosphate/rhBMP-2 composite in rats.
Topics: Animals; Biomechanical Phenomena; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Coloring Agents; Dose-Response Relationship, Drug; Femur; Fluorescent Dyes; Male; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Tolonium Chloride; Transforming Growth Factor beta | 2003 |
[Osteogenic potential of three kinds of calcium phosphate ceramics as carriers for recombinant human morphogenetic protein-2 in vivo].
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Ceramics; Drug Carriers; Drug Implants; Female; Male; Materials Testing; Osteogenesis; Rats; Rats, Wistar; Transforming Growth Factor beta | 2003 |
Collagen-hydroxyapatite/tricalcium phosphate microspheres as a delivery system for recombinant human transforming growth factor-beta 1.
Topics: Animals; Bone Regeneration; Calcium Phosphates; Collagen; Drug Carriers; Drug Delivery Systems; Durapatite; Femur; Male; Microspheres; Rabbits; Recombinant Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2003 |
Enhanced bone augmentation by controlled release of recombinant human bone morphogenetic protein-2 from bioabsorbable membranes.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Bone Diseases; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Humans; Membranes, Artificial; Osteogenesis; Polyesters; Rabbits; Random Allocation; Recombinant Proteins; Skull; Transforming Growth Factor beta; Wound Healing | 2003 |
In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Topics: Animals; Biomechanical Phenomena; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Cell Separation; Cells, Cultured; Ceramics; Ilium; Lumbosacral Region; Male; Models, Animal; Osteoblasts; Osteogenesis; Rabbits; Spinal Fusion; Spine; Stromal Cells; Tomography, X-Ray Computed; Transforming Growth Factor beta; Transplantation, Autologous | 2003 |
rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
Topics: Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Drug Carriers; Glycolates; Humans; Injections; Lactic Acid; Microscopy, Electron, Scanning; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Proteins; Transforming Growth Factor beta | 2003 |
Expression of TGF-beta in region of bone defect repaired by collagen/nano-beta-tricalcium phosphate composite artificial bone.
Topics: Animals; Biocompatible Materials; Calcium Phosphates; Ceramics; Collagen; Fracture Healing; Implants, Experimental; Nanotechnology; Osseointegration; Osteogenesis; Rabbits; Skull Fractures; Transforming Growth Factor beta | 2003 |
rhBMP-2 injected in a calcium phosphate paste (alpha-BSM) accelerates healing in the rabbit ulnar osteotomy model.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bony Callus; Calcium Phosphates; Disease Models, Animal; Drug Carriers; Elasticity; Fracture Healing; Humans; Osteotomy; Rabbits; Recombinant Proteins; Tensile Strength; Torsion Abnormality; Transforming Growth Factor beta; Ulna; Ulna Fractures | 2003 |
The efficacy of BMP-2 to induce bone ingrowth in a total hip replacement model.
Topics: Animals; Arthroplasty, Replacement, Hip; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Dogs; Drug Carriers; Hip Prosthesis; Models, Animal; Osseointegration; Prosthesis Design; Transforming Growth Factor beta | 2003 |
[Preparation of a biphasic calcined bone of beta-TCP/HAP and its application in BMP-2 gene medicine].
Topics: Animals; Biodegradation, Environmental; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Cell Differentiation; Goats; Hydroxyapatites; Materials Testing; Mesenchymal Stem Cells; Mice; Mice, Nude; Transfection; Transforming Growth Factor beta | 2003 |
[Heterotopic osteogenesis of autogenous marrow stromal cells with recombinant human bone morphogenetic protein 2 gene transfection and porous calcium phosphate ceramic as a scaffold].
Topics: Animals; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Ceramics; Male; Osteogenesis; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Stromal Cells; Transfection; Transforming Growth Factor beta | 2003 |
Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Drug Delivery Systems; Female; Implants, Experimental; Materials Testing; Osteogenesis; Rabbits; Recombinant Proteins; Skull Fractures; Transforming Growth Factor beta; Treatment Outcome | 2004 |
Transforming growth factor-beta1 accelerates bone bonding to a blended calcium phosphate ceramic coating: a dose-response study.
Topics: Animals; Bone Cements; Bone Regeneration; Calcium Phosphates; Ceramics; Coated Materials, Biocompatible; Dogs; Dose-Response Relationship, Drug; Femur; Implants, Experimental; Kinetics; Male; Stress, Mechanical; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Bone growth into a ceramic-filled defect around an implant. The response to transforming growth factor beta1.
Topics: Animals; Bone Development; Bone Nails; Bone Substitutes; Calcium Phosphates; Coated Materials, Biocompatible; Durapatite; Male; Rats; Rats, Sprague-Dawley; Tibia; Titanium; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Characterization of a calcium phosphate-based matrix for rhBMP-2.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; CHO Cells; Cricetinae; Extracellular Matrix; Humans; Rats; Tissue Engineering; Transforming Growth Factor beta | 2004 |
Experimental study of carriers of bone morphogenetic protein used for spinal fusion.
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Ceramics; Collagen Type I; Drug Carriers; Lumbar Vertebrae; Materials Testing; Rabbits; Radiography; Spinal Fusion; Tensile Strength; Transforming Growth Factor beta | 2004 |
Beta-tricalcium phosphate combined with recombinant human bone morphogenetic protein-2: a substitute for autograft, used for packing interbody fusion cages in the canine lumbar spine.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Dogs; Drug Therapy, Combination; Internal Fixators; Lumbar Vertebrae; Male; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta | 2004 |
Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy.
Topics: Animals; Biomechanical Phenomena; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Dogs; Female; Injections; Osteotomy; Recombinant Proteins; Tibia; Time Factors; Transforming Growth Factor beta; Wound Healing | 2004 |
A new bone-inducing biodegradable porous beta-tricalcium phosphate.
Topics: Absorbable Implants; Acid Phosphatase; Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Coated Materials, Biocompatible; Dioxanes; Drug Delivery Systems; Humans; Isoenzymes; Lactic Acid; Male; Mice; Mice, Inbred Strains; Microscopy, Electron, Scanning; Polyesters; Polyethylene Glycols; Polymers; Radiography; Recombinant Proteins; Surface Properties; Tartrate-Resistant Acid Phosphatase; Time Factors; Transforming Growth Factor beta | 2004 |
The effect of osteogenic growth factors on bone growth into a ceramic filled defect around an implant.
Topics: Animals; Bone Development; Calcium Phosphates; Ceramics; Fibroblast Growth Factor 2; Implants, Experimental; Insulin-Like Growth Factor I; Male; Osteoblasts; Rats; Rats, Sprague-Dawley; Tibia; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Periodontal repair in dogs: evaluation of a bioresorbable calcium phosphate cement (Ceredex) as a carrier for rhBMP-2.
Topics: Absorbable Implants; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Cementogenesis; Dental Cements; Dogs; Drug Carriers; Furcation Defects; Humans; Male; Oral Surgical Procedures; Recombinant Proteins; Root Resorption; Tooth Ankylosis; Transforming Growth Factor beta | 2004 |
Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model.
Topics: Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Drug Carriers; Fracture Healing; Fractures, Bone; Injections; Macaca fascicularis; Male; Ointments; Osteotomy; Radiography; Time Factors; Transforming Growth Factor beta | 2004 |
Conservation of Bmp2 post-transcriptional regulatory mechanisms.
Topics: 3' Untranslated Regions; Animals; Base Sequence; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Line, Tumor; Chickens; Cloning, Molecular; Cricetinae; Dogs; Evolution, Molecular; Expressed Sequence Tags; Genes, Reporter; Humans; Luciferases; Mice; Molecular Sequence Data; Plasmids; Polyadenylation; Polymerase Chain Reaction; Promoter Regions, Genetic; Ribonucleases; RNA Processing, Post-Transcriptional; RNA, Messenger; Sequence Homology, Nucleic Acid; Species Specificity; Time Factors; Transcription, Genetic; Transfection; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Zebrafish | 2004 |
New scaffold for recombinant human bone morphogenetic protein-2.
Topics: Absorbable Implants; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Humans; Male; Radiography; Rats; Rats, Wistar; Recombinant Proteins; Skull; Transforming Growth Factor beta | 2004 |
Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Drug Delivery Systems; Drug Implants; Female; Implants, Experimental; Materials Testing; Osteogenesis; Porosity; Rabbits; Tissue Engineering; Transforming Growth Factor beta | 2005 |
Cyclosilicate nanocomposite: a novel resorbable bioactive tissue engineering scaffold for BMP and bone-marrow cell delivery.
Topics: Absorption; Alkaline Phosphatase; Animals; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Cells, Cultured; Compressive Strength; Humans; Kinetics; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanostructures; Porosity; Rabbits; Recombinant Fusion Proteins; Silicates; Solubility; Spectroscopy, Fourier Transform Infrared; Tissue Engineering; Transforming Growth Factor beta; X-Ray Diffraction | 2004 |
A biomimetic gelatin-calcium phosphate bone cement.
Topics: Alkaline Phosphatase; Biocompatible Materials; Bone Cements; Calcium Phosphates; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Collagen; Compressive Strength; Gelatin; Hardness; Humans; In Vitro Techniques; Osteoblasts; Powders; Surface Properties; Transforming Growth Factor beta; X-Ray Diffraction | 2004 |
Treatment of periapical inflammatory lesion with the combination of platelet-rich plasma and tricalcium phosphate: a case report.
Topics: Alveolar Bone Loss; Blood Platelets; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Dental Scaling; Follow-Up Studies; Gels; Guided Tissue Regeneration; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Periapical Periodontitis; Plasmapheresis; Platelet-Derived Growth Factor; Root Canal Therapy; Transforming Growth Factor beta | 2004 |
The use of porous calcium phosphate scaffolds with transforming growth factor beta 1 as an onlay bone graft substitute.
Topics: Animals; Bone Cements; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Cattle; Cricetinae; Osteogenesis; Porosity; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 2004 |
Transforming growth factor (TGF)-beta1 releasing tricalcium phosphate/chitosan microgranules as bone substitutes.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Bone Substitutes; Calcium Phosphates; Cell Differentiation; Cell Proliferation; Cell Survival; Chitosan; Mice; Microscopy, Electron, Scanning; Microspheres; Osteocalcin; Powders; Tetrazolium Salts; Thiazoles; Tissue Engineering; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
[Injectable carrier system for growth factor application in minimally invasive stimulation of bone healing].
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Collagen; Drug Carriers; External Fixators; Female; Fracture Healing; Ilizarov Technique; Injections; Pharmaceutical Vehicles; Recombinant Proteins; Sheep; Tibia; Tomography, X-Ray Computed; Transforming Growth Factor beta; Viscosity | 2004 |
Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
Topics: Absorbable Implants; Absorption; Animals; Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Choristoma; Collagen; Drug Carriers; Drug Implants; Male; Materials Testing; Osteogenesis; Rats; Rats, Sprague-Dawley; Tissue Engineering; Transforming Growth Factor beta | 2005 |
Growth factor-loaded scaffolds for bone engineering.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Female; Male; Osteogenesis; Rabbits; Rats; Rats, Wistar; Recombinant Proteins; Tissue Engineering; Titanium; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2.
Topics: Body Fluids; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Coated Materials, Biocompatible; Diffusion; Drug Combinations; Drug Evaluation, Preclinical; Drug Implants; Fibrin Tissue Adhesive; Materials Testing; Polyesters; Transforming Growth Factor beta | 2005 |
TGF-beta1-enhanced TCP-coated sensate scaffolds can detect bone bonding.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Development; Bone Substitutes; Calcium Phosphates; Femur; Materials Testing; Microscopy, Electron; Microscopy, Electron, Scanning; Polyesters; Polymers; Rats; Software; Stress, Mechanical; Surface Properties; Tissue Engineering; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Cell Differentiation; Choristoma; Drug Implants; Male; Materials Testing; Mice; Osteoblasts; Osteogenesis; Porosity; Transforming Growth Factor beta | 2005 |
Cell-mediated protein release from calcium-phosphate-coated titanium implants.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Osseointegration; Osteogenesis; Prostheses and Implants; Rats; Titanium; Transforming Growth Factor beta | 2005 |
Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Delayed-Action Preparations; Diffusion; Female; Gelatin; Mice; Mice, Inbred Strains; Osteoblasts; Osteogenesis; Rats; Rats, Inbred F344; Tissue Engineering; Transforming Growth Factor beta | 2005 |
Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.
Topics: Absorbable Implants; Absorptiometry, Photon; Animals; Biocompatible Materials; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bony Callus; Calcium Phosphates; Femoral Fractures; Femur; Fracture Healing; Guided Tissue Regeneration; Humans; Lactates; Osteogenesis; Polydioxanone; Polyethylene Glycols; Rabbits; Recombinant Proteins; Tomography, Spiral Computed; Transforming Growth Factor beta | 2005 |
Bone regeneration in the rat mandible with bone morphogenetic protein-2: a comparison of two carriers.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Collagen; Drug Carriers; Hyaluronic Acid; Hydroxyapatites; Male; Mandible; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta | 2005 |
Local application of rhTGF-beta2 enhances peri-implant bone volume and bone-implant contact in a rat model.
Topics: Animals; Bone and Bones; Bone Regeneration; Calcium Phosphates; Delayed-Action Preparations; Femur; Growth Substances; Hydroxyapatites; Implants, Experimental; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Shear Strength; Titanium; Tomography, X-Ray Computed; Transforming Growth Factor beta; Transforming Growth Factor beta2 | 2005 |
Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Ceramics; Collagen Type I; Dose-Response Relationship, Drug; Drug Carriers; Implants, Experimental; Lumbar Vertebrae; Macaca mulatta; Models, Animal; Osseointegration; Osteogenesis; Palpation; Recombinant Proteins; Spinal Fusion; Surgical Sponges; Tomography, X-Ray Computed; Transforming Growth Factor beta | 2005 |
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
Topics: Adsorption; Animals; Biocompatible Materials; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Delayed-Action Preparations; Drug Carriers; Glycolates; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta | 2005 |
Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons.
Topics: Absorbable Implants; Alveolar Ridge Augmentation; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Collagen; Drug Carriers; Durapatite; Humans; Least-Squares Analysis; Papio anubis; Random Allocation; Recombinant Proteins; Transforming Growth Factor beta | 2005 |
An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma.
Topics: Absorption; Animals; Blood Platelets; Calcium Phosphates; Drug Delivery Systems; Insulin-Like Growth Factor I; Kinetics; Microscopy, Electron, Scanning; Plasma; Platelet-Derived Growth Factor; Polyesters; Proteins; Swine; Transforming Growth Factor beta; Transforming Growth Factor beta1; Water | 2005 |
Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Drug Delivery Systems; Humans; Lumbar Vertebrae; Models, Animal; Polymers; Rabbits; Radiography; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta | 2005 |
rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations.
Topics: Animals; Biomechanical Phenomena; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bony Callus; Calcium Phosphates; Cell Movement; Fibula; Humans; Macaca fascicularis; Male; Models, Animal; Osteogenesis; Osteotomy; Recombinant Proteins; Rotation; Time Factors; Tomography, X-Ray Computed; Transforming Growth Factor beta; Treatment Outcome; Wound Healing | 2006 |
The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Drug Carriers; Fibrin; Fibronectins; Humans; Male; Osteogenesis; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Skull; Transforming Growth Factor beta | 2006 |
Engineering new bone with bone morphogenic proteins.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Collagen; Humans; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2006 |
Elevated extracellular calcium stimulates secretion of bone morphogenetic protein 2 by a macrophage cell line.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium; Calcium Phosphates; Cell Line; Ions; Macrophages; Mice; Phagocytosis; Phosphates; Transforming Growth Factor beta | 2006 |
In vivo banking for vascularized autograft bone by intramuscular inoculation of recombinant human bone morphogenetic protein-2 and beta-tricalcium phosphate.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Transplantation; Calcium Phosphates; Drug Carriers; Female; Humans; Materials Testing; Muscle, Skeletal; Prostheses and Implants; Rabbits; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta; Transplantation, Autologous | 2006 |
Repair of long intercalated rib defects using porous beta-tricalcium phosphate cylinders containing recombinant human bone morphogenetic protein-2 in dogs.
Topics: Absorbable Implants; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Dogs; Humans; Male; Osteogenesis; Recombinant Proteins; Ribs; Time Factors; Transforming Growth Factor beta | 2006 |
In situ osteogenesis of hemimandible with rhBMP-2 in a 9-year-old boy: osteoinduction via stem cell concentration.
Topics: Biocompatible Materials; Bone Density; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Plates; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Child, Preschool; Collagen; Durapatite; Fibroma, Ossifying; Follow-Up Studies; Humans; Male; Mandible; Mandibular Neoplasms; Neoplasm Recurrence, Local; Osteogenesis; Periosteum; Plastic Surgery Procedures; Recombinant Proteins; Stem Cells; Transforming Growth Factor beta | 2006 |
rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Disease Models, Animal; Osteolysis; Rabbits; Radiography; Radius; Recombinant Proteins; Transforming Growth Factor beta | 2006 |
Superior effect of MD05, beta-tricalcium phosphate coated with recombinant human growth/differentiation factor-5, compared to conventional bone substitutes in the rat calvarial defect model.
Topics: Animals; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Cattle; Collagen; Female; Growth Differentiation Factor 5; Humans; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Skull; Specific Pathogen-Free Organisms; Statistics, Nonparametric; Transforming Growth Factor beta | 2006 |
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin.
Topics: Albumins; Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Drug Delivery Systems; Male; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta | 2006 |
Transforming growth factor-beta1 release from a porous electrostatic spray deposition-derived calcium phosphate coating.
Topics: Animals; Calcium Phosphates; Cell Culture Techniques; Cell Proliferation; Cells, Cultured; Coated Materials, Biocompatible; Drug Implants; Epithelial Cells; Humans; Osteoblasts; Porosity; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Femur; Male; Rats; Rats, Long-Evans; Regeneration; Stress, Mechanical; Tissue Engineering; Tomography, X-Ray Computed; Transforming Growth Factor beta | 2007 |
[Experimental studies on the porous calcium phosphate cement combined with recombinant human bone morphogenetic protein 2 for bone defects repair].
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Disease Models, Animal; Femur; Rabbits; Recombinant Proteins; Transforming Growth Factor beta; Wound Healing | 2006 |
Expression of bone morphogenetic protein 2 and fibroblast growth factor 2 during bone regeneration using different implant materials as an onlay bone graft in rabbit mandibles.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Fibroblast Growth Factor 2; Lactic Acid; Male; Mandible; Models, Animal; Polyesters; Polymers; Rabbits; Radius; Recombinant Proteins; Transforming Growth Factor beta | 2007 |
Delivery mode and efficacy of BMP-2 in association with implants.
Topics: Adsorption; Alloys; Animals; Biomimetic Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Coated Materials, Biocompatible; Dermatologic Surgical Procedures; Implants, Experimental; Male; Models, Animal; Ossification, Heterotopic; Osteogenesis; Rats; Rats, Wistar; Titanium; Transforming Growth Factor beta | 2007 |
Bone morphogenetic proteins-signaling plays a role in tendon-to-bone healing: a study of rhBMP-2 and noggin.
Topics: Animals; Anterior Cruciate Ligament; Biomechanical Phenomena; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Resorption; Calcium Phosphates; Carrier Proteins; Male; Models, Animal; Osseointegration; Plastic Surgery Procedures; Rabbits; Recombinant Proteins; Risk Factors; Signal Transduction; Tendons; Transforming Growth Factor beta | 2007 |
The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Coated Materials, Biocompatible; Dental Implantation, Endosseous; Dental Implants; Implants, Experimental; Materials Testing; Osseointegration; Surface Properties; Swine; Titanium; Transforming Growth Factor beta | 2007 |
Repair of bone defects in revision hip arthroplasty by implantation of a new bone-inducing material comprised of recombinant human BMP-2, Beta-TCP powder, and a biodegradable polymer: an experimental study in dogs.
Topics: Absorbable Implants; Animals; Arthroplasty, Replacement, Hip; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Dogs; Humans; Lactates; Male; Polyethylene Glycols; Recombinant Proteins; Reoperation; Transforming Growth Factor beta | 2007 |
Bone engineering of the rabbit ulna.
Topics: Absorbable Implants; Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Delayed-Action Preparations; Drug Delivery Systems; Guided Tissue Regeneration; Humans; Male; Materials Testing; Nanocomposites; Osseointegration; Prosthesis Design; Rabbits; Recombinant Proteins; Silicates; Tissue Engineering; Transforming Growth Factor beta; Ulna | 2007 |
Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Cells, Cultured; Compressive Strength; Drug-Eluting Stents; Femur; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Recombinant Proteins; Resin Cements; Transforming Growth Factor beta; X-Ray Diffraction | 2008 |
Hollow calcium phosphate microcarriers for bone regeneration: in vitro osteoproduction and ex vivo mechanical assessment.
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Capsules; Cell Differentiation; Cell Proliferation; Cells, Cultured; Delayed-Action Preparations; Drug Carriers; Mesenchymal Stem Cells; Osteoblasts; Osteogenesis; Rats; Rats, Inbred F344; Transforming Growth Factor beta | 2007 |
Bone regeneration using a naturally grown HA/TCP carrier loaded with rh BMP-2 is independent of barrier-membrane effects.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Durapatite; Humans; Implants, Experimental; Membranes, Artificial; Microscopy, Electron, Scanning; Rabbits; Recombinant Proteins; Skull; Tissue Scaffolds; Transforming Growth Factor beta | 2008 |
Molded vascularized neo-ossicle formation in silicone chambers.
Topics: Animals; Bone and Bones; Bone Marrow Cells; Bone Matrix; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Cell Survival; Cells, Cultured; Collagen; Dimethylpolysiloxanes; Equipment Design; Male; Osteoblasts; Osteogenesis; Pilot Projects; Rats; Rats, Inbred Lew; Recombinant Proteins; Silicones; Stem Cells; Time Factors; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2007 |
Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-beta 1 loaded gelatin microparticles.
Topics: Animals; Bone Cements; Calcium Phosphates; Femur; Gelatin; Microscopy, Electron, Scanning; Rabbits; Transforming Growth Factor beta | 2008 |
Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Drug Carriers; Durapatite; Humans; Polyethylene Glycols; Rabbits; Skull; Transforming Growth Factor beta | 2008 |
Self-inducing shape memory geometric cues embedded within smart hydroxyapatite-based biomimetic matrices.
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcium Phosphates; Carbon; Ceramics; Collagen Type IV; Durapatite; Equipment Design; Implants, Experimental; Male; Materials Testing; Morphogenesis; Neovascularization, Physiologic; Osseointegration; Osteoblasts; Papio ursinus; Porosity; Rectus Abdominis; RNA, Messenger; Skull; Tissue Scaffolds; Transforming Growth Factor beta | 2007 |
BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Remodeling; Calcium Phosphates; Cattle; Humans; Male; Recombinant Proteins; Sheep; Transforming Growth Factor beta | 2008 |
Non-viral bone morphogenetic protein 2 transfection of rat dental pulp stem cells using calcium phosphate nanoparticles as carriers.
Topics: Alkaline Phosphatase; Animals; Antigens, Surface; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dental Pulp; Gene Expression Regulation; Humans; Nanoparticles; Odontogenesis; Rats; Stem Cells; Titanium; Transfection; Transforming Growth Factor beta | 2008 |
The effect of calcium phosphate microstructure on bone-related cells in vitro.
Topics: 3T3 Cells; Adsorption; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Calcium Phosphates; Cell Line; Coated Materials, Biocompatible; Hematopoietic Stem Cells; Humans; Materials Testing; Mice; Microscopy, Electron, Scanning; Myoblasts; Osteoblasts; Osteogenesis; Particle Size; Recombinant Proteins; Spectroscopy, Fourier Transform Infrared; Surface Properties; Transforming Growth Factor beta; X-Ray Diffraction | 2008 |
Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Proliferation; Ceramics; Chitosan; Humans; Materials Testing; Mice; Microscopy, Electron, Scanning; Myoblasts; Porosity; Rabbits; Recombinant Proteins; Skull; Spectroscopy, Fourier Transform Infrared; Tissue Engineering; Tissue Scaffolds; Tomography, X-Ray Computed; Transforming Growth Factor beta; X-Ray Diffraction | 2008 |
Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2.
Topics: Alkaline Phosphatase; Animals; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Cell Count; Cells, Cultured; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteoblasts; Osteocalcin; Osteogenesis; Recombinant Proteins; Stromal Cells; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2009 |
Bone regeneration of critical calvarial defect in goat model by PLGA/TCP/rhBMP-2 scaffolds prepared by low-temperature rapid-prototyping technology.
Topics: Animals; Biocompatible Materials; Biomedical Engineering; Bone Diseases; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Cold Temperature; Disease Models, Animal; Female; Goats; Guided Tissue Regeneration; Humans; Imaging, Three-Dimensional; Lactic Acid; Male; Microscopy, Electron, Scanning; Osteogenesis; Pliability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Random Allocation; Recombinant Proteins; Skull; Stress, Mechanical; Surface Properties; Time Factors; Tissue Scaffolds; Tomography, X-Ray Computed; Transforming Growth Factor beta | 2008 |
Effect of surface structure on protein adsorption to biphasic calcium-phosphate ceramics in vitro and in vivo.
Topics: Adsorption; Animals; Calcium Phosphates; Ceramics; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; X-Ray Diffraction | 2009 |
Acceleration of second and fourth metatarsal fracture healing with recombinant human bone morphogenetic protein-2/calcium phosphate cement in horses.
Topics: Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Female; Fracture Healing; Horses; Male; Metatarsal Bones; Osteotomy; Recombinant Proteins; Transforming Growth Factor beta; Treatment Outcome | 2008 |
Clinical use of recombinant human bone morphogenic protein-2 in a whooping crane (Grus americana).
Topics: Animals; Animals, Wild; Birds; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bony Callus; Calcium Phosphates; Fracture Fixation, Internal; Fracture Healing; Fractures, Bone; Fractures, Comminuted; Humeral Fractures; Male; Recombinant Proteins; Transforming Growth Factor beta; Treatment Outcome | 2008 |
Histological changes of an injectable rhBMP-2/calcium phosphate cement in vertebroplasty of rhesus monkey.
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Humans; Injections; Lumbar Vertebrae; Macaca mulatta; Polymethyl Methacrylate; Random Allocation; Recombinant Proteins; Spinal Fractures; Thoracic Vertebrae; Transforming Growth Factor beta; Vertebroplasty | 2009 |
Impact of rhBMP-2 on regeneration of buccal alveolar defects during the osseointegration of transgingival inserted implants.
Topics: Alveolar Bone Loss; Animals; Bone Matrix; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Ceramics; Dental Abutments; Dental Implants; Dental Materials; Dental Prosthesis Design; Dogs; Drug Carriers; Humans; Male; Mandible; Mandibular Diseases; Osseointegration; Osteoblasts; Osteogenesis; Recombinant Proteins; Surface Properties; Time Factors; Transforming Growth Factor beta | 2009 |
Scaffold-based rhBMP-2 therapy in a rat alveolar defect model: implications for human gingivoperiosteoplasty.
Topics: Absorbable Implants; Alveolar Ridge Augmentation; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Cleft Palate; Disease Models, Animal; Female; Gingivoplasty; Humans; Male; Oral Surgical Procedures; Osteogenesis; Periosteum; Plastic Surgery Procedures; Random Allocation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Factors; Transforming Growth Factor beta | 2009 |
Effects of polycaprolactone-tricalcium phosphate, recombinant human bone morphogenetic protein-2 and dog mesenchymal stem cells on bone formation: pilot study in dogs.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Cell Proliferation; Cell Survival; Cells, Cultured; Dogs; Fibrin Tissue Adhesive; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Microscopy, Fluorescence; Osteogenesis; Polyesters; Recombinant Proteins; Transforming Growth Factor beta | 2009 |
Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion.
Topics: Animals; Biomimetic Materials; Bone Morphogenetic Protein 2; Calcium Phosphates; Coated Materials, Biocompatible; Drug Delivery Systems; Humans; Rabbits; Recombinant Proteins; Spinal Fusion; Surgical Sponges; Transforming Growth Factor beta | 2011 |
Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with autologous platelet-rich plasma.
Topics: Animals; Base Sequence; Biomechanical Phenomena; Calcium Phosphates; Cell Proliferation; Chitosan; Core Binding Factor Alpha 1 Subunit; DNA Primers; Goats; Microscopy, Electron, Scanning; Platelet-Rich Plasma; Reverse Transcriptase Polymerase Chain Reaction; Tibia; Transforming Growth Factor beta | 2010 |
The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.
Topics: Adipocytes; Adipose Tissue; Alkaline Phosphatase; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium; Calcium Phosphates; Cell Differentiation; Cells, Cultured; Humans; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Stromal Cells; Tissue Engineering; Transforming Growth Factor beta | 2010 |
Customized Ca-P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Cell Differentiation; Cell Line; Heparin; Humans; Materials Testing; Mesenchymal Stem Cells; Mice; Microspheres; Nanocomposites; Osteogenesis; Polyesters; Recombinant Proteins; Surface Properties; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2010 |
Recombinant human bone morphogenetic protein-2 (rhBMP-2) in the treatment of mandibular sequelae after tumor resection.
Topics: Adult; Ameloblastoma; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Plates; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Collagen; Cutaneous Fistula; Device Removal; Drug Carriers; Durapatite; Equipment Failure; Female; Follow-Up Studies; Humans; Mandibular Neoplasms; Oral Fistula; Plastic Surgery Procedures; Recombinant Proteins; Surgical Mesh; Surgical Wound Dehiscence; Surgical Wound Infection; Transforming Growth Factor beta | 2011 |
Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold.
Topics: Alginates; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Cell Differentiation; Cell Survival; Cells, Cultured; Chitosan; Colorimetry; Glucuronic Acid; Hexuronic Acids; Humans; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; Umbilical Cord | 2011 |
[Study on osteogenic ability of chitosan/beta-tricalcium phosphate scaffold combined with human bone morphogenetic protein].
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Transplantation; Calcium Phosphates; Chitosan; Humans; Osteogenesis; Rabbits; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2010 |
The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration.
Topics: Animals; Biomimetics; Bone Morphogenetic Protein 2; Calcium Phosphates; Coated Materials, Biocompatible; Dental Implantation, Endosseous; Dental Implants; Female; Humans; Microradiography; Microscopy, Electron, Scanning; Osseointegration; Recombinant Proteins; Statistics, Nonparametric; Surface Properties; Swine; Titanium; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2011 |
[Preparation of recombinant human bone morphogenetic protein 2 decorated beta tricalcium phosphate/collagen and preliminary studies on its properties of inducing tooth formation].
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Calcium Phosphates; Collagen; Dental Materials; Female; Humans; Male; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Tooth Germ; Transforming Growth Factor beta | 2011 |
Maxillary sinus floor elevation using a tissue-engineered bone with rhBMP-2-loaded porous calcium phosphate cement scaffold and bone marrow stromal cells in rabbits.
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Differentiation; Humans; Male; Maxillary Sinus; Rabbits; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2011 |
An analysis of bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein 2 from a biodegradable sponge composed of gelatin and β-tricalcium phosphate.
Topics: Animals; Biodegradation, Environmental; Biomechanical Phenomena; Bone and Bones; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Delayed-Action Preparations; Gelatin Sponge, Absorbable; Humans; Rabbits; Radiography; Radius; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta; Ulna | 2012 |
The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
Topics: Analysis of Variance; Animals; Bone Morphogenetic Protein 2; Bony Callus; Calcium Phosphates; Collagen Type I; Drug Delivery Systems; Durapatite; Eosine Yellowish-(YS); Escherichia coli; Femur; Hematoxylin; Humans; Male; Microscopy, Electron, Scanning; Osteogenesis; Osteogenesis, Distraction; Osteopontin; Osteotomy; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Staining and Labeling; Time Factors; Transforming Growth Factor beta; X-Ray Microtomography | 2012 |
Reconstruction of orbital defect in rabbits with composite of calcium phosphate cement and recombinant human bone morphogenetic protein-2.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Phosphates; Female; Male; Microscopy, Electron, Scanning; Orbit; Osteogenesis; Plastic Surgery Procedures; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 2010 |
Osteoinduction in the palatal submucosa by injecting BMP-2 on 2 different carriers.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Cleft Palate; Collagen; Humans; Immunoenzyme Techniques; Injections; Osteogenesis; Palate, Hard; Prostheses and Implants; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 2012 |
Osteogenic differentiation of osteoblasts induced by calcium silicate and calcium silicate/β-tricalcium phosphate composite bioceramics.
Topics: Alkaline Phosphatase; Animals; Bone Morphogenetic Protein 2; Calcium Compounds; Calcium Phosphates; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Ceramics; Core Binding Factor Alpha 1 Subunit; Gene Expression Regulation; Materials Testing; Osteoblasts; Osteogenesis; Rats; Rats, Sprague-Dawley; Silicates; Transforming Growth Factor beta | 2012 |
Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.
Topics: Alkaline Phosphatase; Animals; Bone Marrow Cells; Bone Morphogenetic Protein 2; Calcification, Physiologic; Calcium; Calcium Phosphates; Cell Differentiation; Cells, Cultured; Flavonoids; Gene Expression Regulation; Humans; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Male; Materials Testing; Microscopy, Electron, Scanning; Molecular Weight; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rabbits; Recombinant Proteins; Stem Cells; Tissue Scaffolds; Transforming Growth Factor beta | 2012 |
Bony engineering using time-release porous scaffolds to provide sustained growth factor delivery.
Topics: Adipose Tissue; Alkaline Phosphatase; Analysis of Variance; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Calcium Sulfate; Cell Culture Techniques; Cell Differentiation; Durapatite; Enzyme-Linked Immunosorbent Assay; Humans; Mesenchymal Stem Cells; Porosity; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sp7 Transcription Factor; Staining and Labeling; Tissue Engineering; Tissue Scaffolds; Transcription Factors; Transforming Growth Factor beta | 2012 |
A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and platelet-rich fibrin-mixed tricalcium phosphate in rabbits.
Topics: Animals; Blood Platelets; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Coated Materials, Biocompatible; Drug Carriers; Female; Fibrin; Rabbits; Recombinant Proteins; Sinus Floor Augmentation; Transforming Growth Factor beta | 2012 |
Volumetric bone regenerative efficacy of biphasic calcium phosphate-collagen composite block loaded with rhBMP-2 in vertical bone augmentation model of a rabbit calvarium.
Topics: Animals; Bone Density; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Collagen; Humans; Models, Animal; Osteogenesis; Porosity; Rabbits; Recombinant Proteins; Skull; Tissue Scaffolds; Transforming Growth Factor beta | 2012 |
Tissue-engineered calcium phosphate cement in rabbit femoral condylar bone defects.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Calcium Phosphates; Cells, Cultured; Femur; Rabbits; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2012 |
Intraosseous injection of rhBMP-2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of the femur in chronic ovariectomized nonhuman primates.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Female; Femur Neck; Injections, Intralesional; Macaca fascicularis; Ovariectomy; Recombinant Proteins; Tomography, X-Ray Computed; Transforming Growth Factor beta | 2013 |
Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: a case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration.
Topics: Adipose Tissue; Ameloblastoma; Bone Morphogenetic Protein 2; Bone Plates; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Cell Culture Techniques; Cell Differentiation; Cell Survival; Dental Implants; Dental Prosthesis, Implant-Supported; Denture, Overlay; Denture, Partial; Follow-Up Studies; Humans; Male; Mandibular Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Osseointegration; Osteogenesis; Plastic Surgery Procedures; Recombinant Proteins; Stem Cells; Subcutaneous Fat, Abdominal; Surgical Mesh; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2013 |
Use of recombinant human bone morphogenetic protein 2 for mandible reconstruction.
Topics: Ameloblastoma; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Transplantation; Calcium Phosphates; Female; Follow-Up Studies; Granuloma, Giant Cell; Guided Tissue Regeneration; Humans; Male; Mandibular Diseases; Mandibular Injuries; Mandibular Neoplasms; Mandibular Osteotomy; Mandibular Reconstruction; Middle Aged; Odontogenic Cysts; Recombinant Proteins; Reoperation; Retrospective Studies; Tissue Scaffolds; Transforming Growth Factor beta; Treatment Outcome | 2013 |
[Experimental research on spinal fusion with recombinant human bone morphogenetic protein-2 and bone marrow stromal cell composited tricalcium phosphate (TCP)].
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Cells, Cultured; Combined Modality Therapy; Female; Lumbar Vertebrae; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Osseointegration; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta | 2012 |
Mechanical properties and cytotoxicity of a resorbable bioactive implant prepared by rapid prototyping technique.
Topics: Animals; Biocompatible Materials; Biomechanical Phenomena; Body Fluids; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Death; Humans; Implants, Experimental; Materials Testing; Microscopy, Electron, Scanning; Myocardium; Porosity; Rabbits; Recombinant Proteins; Silicates; Surface Properties; Temperature; Tissue Engineering; Transforming Growth Factor beta; Ulna; Wound Healing | 2013 |
Effects of porous beta-tricalcium phosphate-based ceramics used as an E. coli-derived rhBMP-2 carrier for bone regeneration.
Topics: Alkaline Phosphatase; Animals; Base Sequence; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Ceramics; Collagen Type I; DNA Primers; Escherichia coli; In Vitro Techniques; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta; X-Ray Diffraction | 2013 |
Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: an in vivo study.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Coated Materials, Biocompatible; Dental Implants; Durapatite; Humans; Implants, Experimental; Osseointegration; Recombinant Proteins; Sheep; Surface Properties; Titanium; Transforming Growth Factor beta | 2014 |
RhBMP-2-loaded calcium silicate/calcium phosphate cement scaffold with hierarchically porous structure for enhanced bone tissue regeneration.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Compounds; Calcium Phosphates; Cell Adhesion; Cell Line; Femur; Humans; Male; Mice; Mice, Inbred C57BL; Osteoblasts; Porosity; Rabbits; Recombinant Proteins; Silicates; Tissue Scaffolds; Transforming Growth Factor beta | 2013 |
Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: rescue by chondrogenic pre-induction.
Topics: Adipose Tissue; Adult; Aged; Animals; Biomarkers; Bone and Bones; Bone Marrow Cells; Bone Morphogenetic Protein 6; Calcium Phosphates; Cell Differentiation; Cells, Cultured; Female; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, SCID; Middle Aged; Osteogenesis; Regeneration; Tissue Engineering; Transforming Growth Factor beta | 2013 |
Biological performance of a polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in an ovine thoracic interbody fusion model.
Topics: Absorbable Implants; Animals; Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Phosphates; Diskectomy; Humans; Male; Polyesters; Recombinant Proteins; Scoliosis; Sheep; Spinal Fusion; Thoracic Vertebrae; Tissue Scaffolds; Transforming Growth Factor beta; Transplantation, Autologous | 2014 |
An injectable BMP cocktail for fracture-healing--a study that others have only imagined: commentary on an article by Thomas Lyon, MD, et al.: "Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial
Topics: Bone Morphogenetic Protein 2; Calcium Phosphates; Female; Fractures, Closed; Humans; Male; Recombinant Proteins; Tibial Fractures; Transforming Growth Factor beta | 2013 |
Chitosan scaffolds containing calcium phosphate salts and rhBMP-2: in vitro and in vivo testing for bone tissue regeneration.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Cell Line; Cell Proliferation; Cell Survival; Chitosan; Elastic Modulus; Humans; Kinetics; Male; Materials Testing; Mice; Rabbits; Recombinant Proteins; Rheology; Salts; Tensile Strength; Tissue Scaffolds; Transforming Growth Factor beta; X-Ray Microtomography | 2014 |
Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.
Topics: Animals; Antigens, Neoplasm; Calcium Phosphates; CD8-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Dendritic Cells; Disease Progression; Down-Regulation; Drug Carriers; Female; Hyaluronic Acid; Melanoma, Experimental; Mice; Nanoparticles; Protamines; RNA, Small Interfering; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tumor Microenvironment; Vaccination | 2014 |
Bioactivity of porous biphasic calcium phosphate enhanced by recombinant human bone morphogenetic protein 2/silk fibroin microsphere.
Topics: Animals; Biocompatible Materials; Bombyx; Bone and Bones; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cells, Cultured; Durapatite; Female; Fibroins; Humans; Kinetics; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Microspheres; Placenta; Porosity; Pregnancy; Recombinant Proteins; Sodium Chloride; Stress, Mechanical; Time Factors; Transforming Growth Factor beta | 2014 |
Mandibular reconstruction using a calcium phosphate/polyethylene glycol hydrogel carrier with BMP-2.
Topics: Alveolar Bone Loss; Alveolar Process; Animals; Biocompatible Materials; Bone Density; Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Phosphates; Drug Carriers; Female; Hydrogel, Polyethylene Glycol Dimethacrylate; Jaw, Edentulous, Partially; Mandible; Mandibular Diseases; Mandibular Reconstruction; Osteogenesis; Random Allocation; Recombinant Proteins; Swine; Swine, Miniature; Transforming Growth Factor beta | 2014 |
The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Morphogenetic Protein 2; Calcium Phosphates; Diabetes Mellitus, Type 1; Disease Models, Animal; Durapatite; Femur; Male; Osteogenesis; Osteoporosis; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta; X-Ray Microtomography | 2015 |
Effect of calcium phosphate coating and rhBMP-2 on bone regeneration in rabbit calvaria using poly(propylene fumarate) scaffolds.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Coated Materials, Biocompatible; Delayed-Action Preparations; Female; Fumarates; Humans; Imaging, Three-Dimensional; Kinetics; Polypropylenes; Porosity; Rabbits; Recombinant Proteins; Skull; Spectrometry, X-Ray Emission; Tissue Scaffolds; Transforming Growth Factor beta; X-Ray Microtomography | 2015 |
Efficient bone formation in a swine socket lift model using Escherichia coli-derived recombinant human bone morphogenetic protein-2 adsorbed in β-tricalcium phosphate.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Escherichia coli; Humans; Male; Osteogenesis; Recombinant Proteins; Swine; Transforming Growth Factor beta | 2014 |
Graded porous β-tricalcium phosphate scaffolds enhance bone regeneration in mandible augmentation.
Topics: Alveolar Ridge Augmentation; Animals; Bone Density; Bone Morphogenetic Protein 2; Bone Regeneration; Calcification, Physiologic; Calcium Phosphates; Fluorescent Dyes; Male; Mandible; Microscopy, Electron, Scanning; Osteogenesis; Porosity; Rabbits; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta; X-Ray Microtomography | 2015 |
Bone regenerative efficacy of biphasic calcium phosphate collagen composite as a carrier of rhBMP-2.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Collagen; Drug Carriers; Models, Animal; Rabbits; Recombinant Proteins; Skull; Transforming Growth Factor beta | 2016 |
BMP-2-transduced human bone marrow stem cells enhance neo-bone formation in a rat critical-sized femur defect.
Topics: Adolescent; Adult; Animals; Bone Marrow Cells; Bone Morphogenetic Protein 2; Calcium Phosphates; Femur; Fluorescent Dyes; Humans; Male; Middle Aged; Osteogenesis; Rats; Rats, Nude; Recombinant Proteins; Stem Cell Transplantation; Stem Cells; Tissue Scaffolds; Transduction, Genetic; Transforming Growth Factor beta; Wound Healing; Young Adult | 2017 |
Tyrosine-derived polycarbonate scaffolds for bone regeneration in a rabbit radius critical-size defect model.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Humans; Materials Testing; Polycarboxylate Cement; Rabbits; Radius; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta; Tyrosine; X-Ray Microtomography | 2015 |
A new concept for implant fixation: bone-to-bone biologic fixation.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Calcium Phosphates; Female; Humans; Orthopedic Procedures; Osseointegration; Pedicle Screws; Recombinant Proteins; Swine; Swine, Miniature; Time Factors; Titanium; Torque; Transforming Growth Factor beta; X-Ray Microtomography | 2015 |
Lhx8 mediated Wnt and TGFβ pathways in tooth development and regeneration.
Topics: Adult; Adult Stem Cells; Animals; Calcium Phosphates; Cell Differentiation; Cells, Cultured; Dental Pulp; Dentinogenesis; Female; Gene Expression Regulation, Developmental; Humans; LIM-Homeodomain Proteins; Mice; Odontogenesis; Regeneration; Signal Transduction; Tissue Scaffolds; Tooth; Transcription Factors; Transforming Growth Factor beta; Wnt Proteins | 2015 |
Microsphere-based gradient implants for osteochondral regeneration: a long-term study in sheep.
Topics: Animals; Bone and Bones; Calcium Phosphates; Cartilage, Articular; Chondrocytes; Chondroitin Sulfates; Female; Femur; Finite Element Analysis; Humans; Hyaline Cartilage; Inflammation; Knee Joint; Lactic Acid; Magnetic Resonance Imaging; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Regeneration; Sheep; Stress, Mechanical; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2015 |
Bone graft substitutes and bone morphogenetic proteins for osteoporotic fractures: what is the evidence?
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Morphogenetic Protein 2; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Calcium Sulfate; Disease Models, Animal; Fracture Healing; Osteoporotic Fractures; Rats; Tissue Scaffolds; Transforming Growth Factor beta | 2016 |
Antigen-free bovine cancellous bone loaded with recombinant human bone morphogenetic protein-2 for the repair of tibial bone defects in goat model.
Topics: Animals; Antigens; Bone Morphogenetic Protein 2; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Cancellous Bone; Cattle; Collagen; Female; Fracture Healing; Gene Expression; Goats; Humans; Male; Osteogenesis; Porosity; Recombinant Proteins; Tibia; Tissue Scaffolds; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2016 |
Magnesium modification up-regulates the bioactivity of bone morphogenetic protein-2 upon calcium phosphate cement via enhanced BMP receptor recognition and Smad signaling pathway.
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Protein Receptors; Calcium Phosphates; Cell Differentiation; Cell Line; Humans; Magnesium; Osteogenesis; Recombinant Proteins; Signal Transduction; Transforming Growth Factor beta | 2016 |
Sustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrier.
Topics: Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Phosphates; Cell Line; Delayed-Action Preparations; Diffusion; Equipment Design; Humans; Hydrogels; Materials Testing; Osteoblasts; Osteogenesis; Porosity; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta | 2016 |
Bioinspired Collagen-Apatite Nanocomposites for Bone Regeneration.
Topics: Animals; Apatites; Bone Regeneration; Calcium Phosphates; Collagen; Extracellular Matrix; Mandible; Nanocomposites; Rats; Sp7 Transcription Factor; Tissue Scaffolds; Transcription Factors; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; X-Ray Microtomography | 2016 |
Local co-application of zoledronate promotes long-term maintenance of newly formed bone induced by recombinant human bone morphogenetic protein 2.
Topics: Animals; Bone Density Conservation Agents; Bone Development; Bone Morphogenetic Protein 2; Calcium Phosphates; Diphosphonates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Imidazoles; Male; Mice; Mice, Inbred ICR; Osteogenesis; Recombinant Proteins; Transforming Growth Factor beta; Treatment Outcome; Zoledronic Acid | 2016 |
Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.
Topics: Adult; Aged; Aged, 80 and over; Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Phosphates; Female; Follow-Up Studies; Humans; Lumbar Vertebrae; Male; Middle Aged; Osseointegration; Prospective Studies; Prostheses and Implants; Recombinant Proteins; Registries; Spinal Fusion; Transforming Growth Factor beta; Visual Analog Scale | 2017 |
RhBMP-2 loaded 3D-printed mesoporous silica/calcium phosphate cement porous scaffolds with enhanced vascularization and osteogenesis properties.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Compounds; Calcium Phosphates; Cell Differentiation; Femur; Humans; Osteogenesis; Printing, Three-Dimensional; Rabbits; Recombinant Proteins; Silicates; Silicon Dioxide; Tissue Scaffolds; Transforming Growth Factor beta | 2017 |
Bicomponent fibrous scaffolds made through dual-source dual-power electrospinning: Dual delivery of rhBMP-2 and Ca-P nanoparticles and enhanced biological performances.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Line; Cell Proliferation; Cell Survival; Drug Delivery Systems; Humans; Mice; Nanofibers; Nanoparticles; Osteogenesis; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2017 |
rhBMP2-loaded calcium phosphate cements combined with allogenic bone marrow mesenchymal stem cells for bone formation.
Topics: Animals; Bone Cements; Bone Marrow Cells; Bone Morphogenetic Protein 2; Calcium Phosphates; Dogs; Humans; Mesenchymal Stem Cells; Mice; Mice, Nude; Osteogenesis; Recombinant Proteins; Transforming Growth Factor beta | 2017 |
Cryogenic 3D printing for producing hierarchical porous and rhBMP-2-loaded Ca-P/PLLA nanocomposite scaffolds for bone tissue engineering.
Topics: Bone and Bones; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Physiological Phenomena; Cells, Cultured; Cold Temperature; Humans; Nanocomposites; Osteogenesis; Polyesters; Printing, Three-Dimensional; Recombinant Proteins; Stem Cells; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2017 |
Protein engineering of recombinant human bone morphogenetic protein 2 with higher interaction with Ca phosphate based scaffold used for osteogenesis.
Topics: Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Differentiation; Cells, Cultured; Cloning, Molecular; Humans; Mesenchymal Stem Cells; Molecular Dynamics Simulation; Osteoblasts; Osteogenesis; Point Mutation; Porosity; Protein Engineering; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta | 2017 |
Use of a fluorescent probe to monitor the enhanced affinity of rh-BMP-2 to silicated-calcium phosphate synthetic bone graft substitutes under competitive conditions.
Topics: Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Phosphates; Fluorescent Dyes; Humans; Recombinant Proteins; Transforming Growth Factor beta | 2017 |
Strontium doping promotes bioactivity of rhBMP-2 upon calcium phosphate cement via elevated recognition and expression of BMPR-IA.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein Receptors, Type I; Calcium Phosphates; Cell Line; Mice; Recombinant Proteins; Strontium; Transforming Growth Factor beta | 2017 |
The accelerated effect of recombinant human bone morphogenetic protein 2 delivered by β-tricalcium phosphate on tendon-to-bone repair process in rabbit models.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Calcium Phosphates; Disease Models, Animal; Drug Delivery Systems; Female; Humerus; Plastic Surgery Procedures; Rabbits; Recombinant Proteins; Rotator Cuff; Rotator Cuff Injuries; Shoulder Joint; Tendons; Transforming Growth Factor beta | 2018 |
αBSM failed as a carrier of rhBMP-2 to enhance bone consolidation in a sheep model of distraction osteogenesis.
Topics: Absorptiometry, Photon; Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Bone Morphogenetic Protein 2; Calcium Phosphates; Drug Carriers; Female; Osteogenesis, Distraction; Recombinant Proteins; Sheep; Torsion, Mechanical; Transforming Growth Factor beta | 2017 |
Chitosan/biphasic calcium phosphate scaffolds functionalized with BMP-2-encapsulated nanoparticles and RGD for bone regeneration.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Cell Adhesion; Cell Differentiation; Cell Proliferation; Chitosan; Immobilized Proteins; Kinetics; Nanoparticles; Oligopeptides; Particle Size; Rabbits; Rats, Sprague-Dawley; Recombinant Proteins; Serum Albumin, Bovine; Static Electricity; Tissue Scaffolds; Transforming Growth Factor beta | 2018 |
Combining Calcium Phosphates with Polysaccharides: A Bone-Inspired Material Modulating Monocyte/Macrophage Early Inflammatory Response.
Topics: Bone and Bones; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Chemokine CCL2; Chitosan; Gene Expression Regulation; Humans; Hyaluronan Receptors; Hyaluronic Acid; Inflammation; Interleukins; Mitochondria; Reactive Oxygen Species; Receptors, Calcium-Sensing; Signal Transduction; THP-1 Cells; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vinculin | 2018 |
The topography and proliferative activity of cells immunoreactive to various growth factors in rat femoral bone tissues after experimental fracture and implantation of titanium implants with bioactive biodegradable coatings.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Proliferation; Coated Materials, Biocompatible; Durapatite; Femoral Fractures; Femur; Male; Osteogenesis; Prostheses and Implants; Rats; Surface Properties; Titanium; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2019 |
Poly (propylene fumarate)/β-calcium phosphate composites for enhanced bone repair.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Cements; Bone Development; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Survival; Compressive Strength; Cross-Linking Reagents; Femur; Fumarates; Humans; Hydrogen-Ion Concentration; Male; Materials Testing; Polypropylenes; Pressure; Rabbits; Recombinant Proteins; Stress, Mechanical; Surface Properties; Temperature; Transforming Growth Factor beta | 2019 |
Preparation of beta-tricalcium phosphate microsphere-hyaluronic acid-based powder gel composite as a carrier for rhBMP-2 injection and evaluation using long bone segmental defect model.
Topics: Animals; Bone Marrow; Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Phosphates; Cortical Bone; Drug Carriers; Drug Liberation; Female; Humans; Hyaluronic Acid; Hydrogels; Injections; Kinetics; Microspheres; Osseointegration; Osteogenesis; Porosity; Prostheses and Implants; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta; Water | 2019 |
Controlled release of BMP-2 from titanium with electrodeposition modification enhancing critical size bone formation.
Topics: Alloys; Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Liberation; Electroplating; Humans; Mice; Neovascularization, Physiologic; Osteogenesis; Oxidation-Reduction; Prostheses and Implants; Rabbits; Recombinant Proteins; Skull; Titanium; Transforming Growth Factor beta | 2019 |
Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Resorption; Calcium Phosphates; Female; Humans; Osteogenesis; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 2020 |
Multifunctional fibrous scaffolds for bone regeneration with enhanced vascularization.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Cells, Cultured; Female; Human Umbilical Vein Endothelial Cells; Humans; Materials Testing; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Optical Imaging; Particle Size; Recombinant Proteins; Surface Properties; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; Vascular Endothelial Growth Factors | 2020 |
Efficacy of three-dimensionally printed polycaprolactone/beta tricalcium phosphate scaffold on mandibular reconstruction.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Dogs; Male; Mandible; Mandibular Reconstruction; Polyesters; Printing, Three-Dimensional; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2020 |
Use of three-dimensionally printed β-tricalcium phosphate synthetic bone graft combined with recombinant human bone morphogenic protein-2 to treat a severe radial atrophic nonunion in a Yorkshire terrier.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Transplantation; Calcium Phosphates; Dogs; Fractures, Malunited; Male; Printing, Three-Dimensional; Radius Fractures; Recombinant Proteins; Transforming Growth Factor beta | 2020 |
Three-dimensionally printed polycaprolactone/beta-tricalcium phosphate scaffold was more effective as an rhBMP-2 carrier for new bone formation than polycaprolactone alone.
Topics: Alkaline Phosphatase; Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Cell Proliferation; Dogs; Drug Carriers; Male; Mandible; Osteogenesis; Polyesters; Printing, Three-Dimensional; Recombinant Proteins; Stem Cells; Tissue Scaffolds; Transforming Growth Factor beta | 2021 |
Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis.
Topics: Actins; Calcium Phosphates; Collagen; Dermis; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Humans; Indoles; Interleukin-6; Platelet-Derived Growth Factor; Receptor, Transforming Growth Factor-beta Type I; Skin; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2020 |
Preliminary evaluation of BMP-2-derived peptide in repairing a peri-implant critical size defect: A canine model.
Topics: Animals; Bone Regeneration; Calcium Phosphates; Collagen; Disease Models, Animal; Dogs; Male; Recombinant Proteins; Transforming Growth Factor beta; X-Ray Microtomography | 2021 |
Bone Regeneration of a 3D-Printed Alloplastic and Particulate Xenogenic Graft with rhBMP-2.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Dogs; Durapatite; Humans; Jaw; Jaw Abnormalities; Maxillofacial Development; Printing, Three-Dimensional; Recombinant Proteins; Skull; Transforming Growth Factor beta | 2021 |
Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
Topics: Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Transplantation; Calcium Phosphates; Cyclophosphamide; Diphosphonates; Disease Models, Animal; Female; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Recombinant Proteins; Tooth Extraction; Transforming Growth Factor beta; Wound Healing; Zoledronic Acid | 2021 |
Effects of rhBMP-2-loaded hydroxyapatite granules/beta-tricalcium phosphate hydrogel (HA/β-TCP/hydrogel) composite on a rat model of caudal intervertebral fusion.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Hydrogels; Hydroxyapatites; Ilium; Rats; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta | 2022 |
Concentration-Dependent Efficacy of Recombinant Human Bone Morphogenetic Protein-2 Using a HA/β-TCP Hydrogel Carrier in a Mini-Pig Vertebral Oblique Lateral Interbody Fusion Model.
Topics: Animals; Bone Morphogenetic Protein 2; Humans; Hydrogels; Recombinant Proteins; Spinal Fusion; Swine; Swine, Miniature; Transforming Growth Factor beta | 2023 |
Unravelling the Basic Calcium Phosphate crystal-dependent chondrocyte protein secretome; a role for TGF-β signaling.
Topics: Calcium Phosphates; Chondrocytes; Chromatography, Liquid; Culture Media, Conditioned; Humans; Interleukin-6; Osteoarthritis; Proteomics; Secretome; Signal Transduction; Tandem Mass Spectrometry; Transforming Growth Factor beta | 2023 |